Kerrisdale Advisers, LLC Laboratory Corp Of America Holdings Transaction History

Kerrisdale Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$197.69 - $227.29 $143,325 - $164,785	-725 Reduced 14.23%	4,369 $993,000
Q3 2023 Nov 14, 2023	SELL	$201.05 - $221.7 $1.55 Million - $1.71 Million	-7,701 Reduced 60.19%	5,094 $1.02 Million
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $2.74 Million - $3.56 Million	12,795 New	12,795 $3 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $2.04 Million - $2.54 Million	-9,964 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $13.3 Million - $15.3 Million	-71,188 Reduced 87.72%	9,964 $2.03 Million
Q3 2020 Nov 16, 2020	BUY	$167.03 - $201.3 $13.6 Million - $16.3 Million	81,152 New	81,152 $15.3 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Kerrisdale Advisers, LLC with notifications on news.